Latest News & Features
Patents
As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. 29 October 2024
Patents
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 29 October 2024
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing. 29 October 2024
Patents
On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a significant shift, with courts adopting a more stringent stance on the criteria of enablement and written description. 29 October 2024
Patents
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration. 29 October 2024
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Patents
There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.